The Future of Biotechnology
Cellular machinery is sophisticated. This isn’t just big data, it’s insanely big data that can be paired with the right software to make new medicines, fuels, and structural materials. Andrew Hessel is a futurist and catalyst in biological technologies, helping industry, academics, and authorities better understand the changes happening in life science. He is a Distinguished Researcher with Autodesk in their Bio/Nano Research Group, based out of San Francisco. He is also the co-founder of the Pink Army Cooperative, the world’s first cooperative biotechnology company, which is aiming to make open source viral therapies for cancer.